We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Global Vacuum Blood Collection Tube Market Driven by Increasing Infectious Diseases

By LabMedica International staff writers
Posted on 27 Sep 2023
Print article
Image: The global vacuum blood collection tube market is projected to reach USD 3.20 billion by 2030 (Photo courtesy of Freepik)
Image: The global vacuum blood collection tube market is projected to reach USD 3.20 billion by 2030 (Photo courtesy of Freepik)

The vacuum blood collection tube market is expanding significantly because these tubes are crucial for diagnosing various medical issues, from infections and anemia to more serious conditions like leukemia and kidney dysfunction. These tubes are indispensable for laboratory tests, helping healthcare providers to start treatments for different illnesses in a timely manner. In comparison to the conventional methods of drawing blood with syringes, vacuum tubes offer multiple benefits. They provide a safer experience for those drawing the blood and ensure cleaner samples because there's less handling and transferring. These tubes are also simpler to use and contain pre-mixed additives. The tubes come with color-coded caps, making it easier for healthcare professionals to understand and communicate about the tests needed. Additionally, they allow for multiple samples to be taken at once, which lowers the chances of damaging the blood cells or hemolysis. Using these vacuum tubes, or "vacutainers," improves the efficiency of diagnostic procedures, shortens the time needed to collect blood samples, and reduces the potential for injuries from needles as well as the risk of sample contamination.

The global vacuum blood collection tube market is projected to register a Compound Annual Growth Rate (CAGR) of 3.02% during the forecast period 2023 – 2030 to reach USD 3.20 billion by the year 2030. Several factors are driving the market's growth, including the rising prevalence of chronic and infectious diseases, and the growing incidence of hematological disorders. In addition, the emergence and re-emergence of infectious diseases pose a significant public health threat, driving the demand for blood collection tubes for clinical diagnostics. The demand for blood collection tubes for clinical diagnostics is expected to increase on account of frequent disease outbreaks in endemic regions. The increase in blood donations is also expected to result in an increase in the usage of blood collection tubes, thereby fueling market growth. However, the vacuum blood collection tube market is plagued by certain challenges, such as a shortage of skilled personnel and low awareness of products in low- and middle-income regions.

These are the latest findings of Research and Markets (Dublin, Ireland), a source for international market research reports.

Based on type, the serum-separating tube segment held the largest share of the vacuum blood collection tube market in 2022, mainly due to the benefits of the barrier gel, which allows for rapid separation of serum from cellular components in blood, thereby reducing hemolysis. By material, the PET/plastic material segment dominated the vacuum blood collection tube market in 2022 due to its advantages over glass, including lower exposure to biohazardous material following breakage, tolerance of higher centrifugation speeds, greater shock resistance, lighter weight, and simpler disposal using cost-effective incineration.

Based on application, the blood routine examination segment held the largest share of the vacuum blood collection tube market in 2022, driven by the prevalence of lifestyle diseases and growing awareness of routine medical examinations. By end-user, pathology laboratories dominated the vacuum blood collection tube market in 2022, led by the high prevalence of diseases such as hepatitis B, HIV AIDS, diabetes, cancer, and heart diseases, which require different types of blood tests to gauge disease severity. Geographically, North America dominated the global vacuum blood collection tube market in 2022, due to the presence of leading clinical diagnostics companies, well-developed healthcare infrastructure, and higher R&D activities in the region.

Related Links:
Research and Markets 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.